Amicus Therapeutics, Inc. (FOLD) Insider Ownership

Historic Insider Ownership Trends

According to recent filings covering the 90 days ending January 09, 2026, the three most significant insider holders at Amicus Therapeutics are President And Ceo Bradley L Campbell (1.02Mn shares), Executive Chairman John F Crowley (573.48K shares), Chief Legal Officer Ellen Rosenberg (464.60K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares Report Date
Bradley L Campbell President And Ceo 1,021,180 30 Dec, 2025
John F Crowley Executive Chairman 573,478 05 Mar, 2024
Ellen Rosenberg Chief Legal Officer 464,601 06 Jan, 2026
Hung Do Chief Science Officer 448,617 08 Apr, 2021
Jeff Castelli Chief Development Officer 409,311 06 Jan, 2026
Daphne Quimi Chief Financial Officer 398,532 19 Jan, 2023
David Michael Clark Chief People Officer 221,811 06 Jan, 2026
Simon N.R. Harford Chief Financial Officer 143,595 30 Dec, 2025
Samantha Prout Chief Accounting Officer 125,951 06 Jan, 2026
Burke W Whitman 118,598 06 Jun, 2025
Michael Raab 115,857 06 Jun, 2025
Glenn Sblendorio 115,857 06 Jun, 2025
Lynn Dorsey Bleil 113,941 06 Jun, 2025
Margaret G Mcglynn 91,550 06 Jun, 2025
Craig A Wheeler 84,631 06 Jun, 2025
Eiry Roberts 76,275 06 Jun, 2025
Michael Aaron Kelly 72,468 06 Jun, 2025
Robert Essner 31,115 14 Jun, 2021

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
03 Jan, 2026 Jeff Castelli Common Stock D 23,102 $14.27 409,311 D F
03 Jan, 2026 Ellen Rosenberg Common Stock D 29,683 $14.27 464,601 D F
03 Jan, 2026 Samantha Prout Common Stock D 12,240 $14.27 125,951 D F
03 Jan, 2026 David Michael Clark Common Stock D 18,498 $14.27 221,811 D F
02 Jan, 2026 Jeff Castelli Common Stock D 6,905 $14.27 432,413 D F
02 Jan, 2026 Ellen Rosenberg Common Stock D 13,426 $14.27 494,284 D F
02 Jan, 2026 Samantha Prout Common Stock D 3,443 $14.27 138,191 D F
02 Jan, 2026 David Michael Clark Common Stock D 5,381 $14.27 240,309 D F
26 Dec, 2025 Bradley L Campbell Common Stock D 108,602 $14.25 1,021,180 D F
26 Dec, 2025 Simon N.R. Harford - - 143,595 D
26 Dec, 2025 Simon N.R. Harford Common Stock D 71,303 $14.25 143,595 D F
19 Dec, 2025 David Michael Clark Common Stock D 25,642 $14.17 245,690 D S
15 Dec, 2025 Bradley L Campbell Common Stock A 70,426 $9.03 1,207,708 D M
15 Dec, 2025 Bradley L Campbell Common Stock D 77,926 $10.86 1,129,782 D S
15 Dec, 2025 David Michael Clark Common Stock D 25,643 $11.00 271,332 D S
01 Dec, 2025 Bradley L Campbell Common Stock D 14,587 $10.01 1,137,282 D S
01 Dec, 2025 Bradley L Campbell Common Stock A 14,587 $9.03 1,151,869 D M
01 Dec, 2025 Samantha Prout Common Stock A 32,193 $0.00 141,634 D A
26 Nov, 2025 Ellen Rosenberg Common Stock A 23,621 $5.13 531,331 D M
26 Nov, 2025 Ellen Rosenberg Common Stock D 23,621 $10.00 507,710 D S